Research Study for Treatment of Children and Adolescents With Acute Myeloid Leukaemia 0-18 Years

NCT01828489 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

300

Enrollment

OTHER_GOV

Sponsor class

Conditions

Pediatric Acute Myeloblastic Leukemia

Interventions

DRUG: Randomisation course 1 mitoxantrone versus DaunoXome
DRUG: Randomisation course 2 ADxE versus FLADx

Sponsor

Vastra Gotaland Region